Methylprednisolone Acetate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Methylprednisolone Acetate Injection (injection) from Pfizer Inc. with status Current. The shortage was first posted on 12/15/2021. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Pfizer Inc.
- Package NDC
- 0009-3073-23
- Dosage Form
- Injection
- Presentation
- Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23)
- Initial Posting
- 12/15/2021
- Revised Date
Reason
Other